Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats

Autor: Raymond Berges, Marie-Jeanne Davicco, Pascal Phrakonkham, Yves Artur, Catherine Bennetau-Pelissero, Catherine Desmetz, Marie-Chantal Canivenc-Lavier, Véronique Coxam, Marie-France Pinnert, Emmanuel Jover, Joëlle Chevalier

Publikováno v: Toxicology and Applied Pharmacology
Toxicology and Applied Pharmacology, Elsevier, 2007, 224 (2), pp.105-115. ⟨10.1016/j.taap.2007.06.012⟩
Toxicology and Applied Pharmacology, 2007, 224 (2), pp.105-115. ⟨10.1016/j.taap.2007.06.012⟩

International audience; The use of soy isoflavones is a potential alternative to hormone replacement therapy in post-menopausal bone-loss prevention. Nevertheless, phytoestrogens can target other organs and may disrupt cell proliferation, or could mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f435ad077c1d25e2db9f749b2e67bd
https://hal.inrae.fr/hal-02661034